(AUROPHARMA) Aurobindo Pharma ForceIndex charts technical analysis
(AUROPHARMA) Aurobindo Pharma ForceIndex charts technical analysis ForceIndex analysis of Aurobindo Pharma | Buy/Sell Aurobindo Pharma
Aurobindo Pharma trades in NSE in Pharmaceuticals sector.
10 day averaged volume of Aurobindo Pharma is 2383144
Date | Closing Price | Open | High | Low | Volume |
09 Wed Apr 2025 | 1058.00 | 1056.10 | 1076.50 | 1042.20 | 2.53 Mn |
08 Tue Apr 2025 | 1097.00 | 1100.30 | 1128.90 | 1091.15 | 0.68 Mn |
07 Mon Apr 2025 | 1094.05 | 1010.00 | 1109.80 | 1010.00 | 2.734 Mn |
04 Fri Apr 2025 | 1105.35 | 1177.00 | 1179.45 | 1050.10 | 7.152 Mn |
03 Thu Apr 2025 | 1176.35 | 1229.00 | 1267.30 | 1173.05 | 7.502 Mn |
02 Wed Apr 2025 | 1157.85 | 1133.00 | 1161.95 | 1117.40 | 1.037 Mn |
01 Tue Apr 2025 | 1134.15 | 1156.50 | 1186.20 | 1126.45 | 1.121 Mn |
28 Fri Mar 2025 | 1160.50 | 1165.10 | 1176.00 | 1148.45 | 0.691 Mn |
27 Thu Mar 2025 | 1164.25 | 1150.00 | 1170.60 | 1131.85 | 1.209 Mn |
26 Wed Mar 2025 | 1157.45 | 1191.00 | 1208.90 | 1155.00 | 0.812 Mn |
Indicators analysis of Aurobindo Pharma (AUROPHARMA)
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
ForceIndex charts
Price action analysis of Aurobindo Pharma ( (AUROPHARMA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aurobindo Pharma ( (AUROPHARMA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aurobindo Pharma ( (AUROPHARMA) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aurobindo Pharma ( (AUROPHARMA) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Aurobindo Pharma stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Aurobindo Pharma in short term and the sell signal is strong.
Aurobindo Pharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Aurobindo Pharma in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Aurobindo Pharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1129.48 and Aurobindo Pharma (AUROPHARMA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Aurobindo Pharma (AUROPHARMA) stock. Volume based technical analysis of Aurobindo Pharma (AUROPHARMA) stock is negative.
Aurobindo Pharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Click here for Aurobindo Pharma charts
Click here for further forecast and predictions for tomorrow
COMMODITY Gainers BSE Gainers BSE Losers BSE Scanner CLOSED NEAR HIGH BSE Scanner CLOSED NEAR LOW USA Gainers USA Losers USA Scanner CLOSED NEAR HIGH USA Scanner CLOSED NEAR LOW USA Scanner UPTRENDING USA Scanner DOWNTRENDING
Munafa NEWSTerms of Use Stock Market News! © munafa.org.in2025 All Rights reserved.